Summary Gut microbiota are deeply associated with the prevalence of obesity. Agarose is hydrolyzed easily to yield oligosaccharides, designated as agaro-oligosaccharides (AGO). This study evaluated the effects of AGO on obese phenotype and gut microbial composition in mice. Mice were administered AGO in drinking water (AGO-receiving mice). 16S rRNA gene sequencing analyses revealed their fecal microbiota profiles. Serum bile acids were ascertained using a LC-MS/MS system. Compared to the control group, AGO administration significantly reduced epididymal adipose tissue weights and serum non-esterified fatty acid concentrations, but the cecal content weights were increased. Data from the serum bile acid profile show that concentrations of primary bile acids (cholic acid and chenodeoxycholic acid), but not those of secondary bile acids (deoxycholic acid, lithocholic acid, and ursodeoxycholic acid), tended to increase in AGO-receiving mice. 16S rRNA gene sequencing analyses showed that the relative abundances of 15 taxa differed significantly in AGO-receiving mice. Of these, the relative abundances of Rikenellaceae and Lachnospiraceae were found to be positively correlated with epididymal adipose tissue weight. The relative abundances of Bacteroides and Ruminococcus were correlated negatively with epididymal adipose tissue weight. Although the definitive role of gut microbes of AGO-received mice is still unknown, our data demonstrate the possibility that AGO administration affects the gut microbial composition and inhibits obesity in mice.
The prevalence of obesity, characterized by excess accumulation of adipose tissue, is increasing at an alarming rate worldwide (1) . Obesity is the most common risk factor for metabolic disorders such as type 2 diabetes and hyperlipidemia; such disorders can lead to several life-threatening complications including blindness, kidney failure, and heart disease. Consequently, it is important to investigate new drugs and functional foods that can cure and/or prevent these disorders.
Accumulating evidence demonstrates that the gut microbiota and its metabolites affect body weight and energy homeostasis (2) (3) (4) . The current use of genomicsbased molecular techniques such as metabolomics and metagenomics has boosted studies aimed at clarifying the precise relation between gut microbiota and obesity (5) . Results of several studies have shown an association of obesity with increased bacteria of the phylum Firmicutes and decreased bacteria of the phylum Bacteroidetes (6) . It is particularly interesting that microbiota from lean twins can protect against obesity induced by microbiota from obese twins, when transferred to mice (7) . Consequently, these reports highlight important roles of gut microbiota in metabolic regulation.
Dietary fiber, which comprises complex polysaccharides resistant to digestion by amylases and glycoamylases in the small intestine, has gained considerable attention and is regarded as crucially important for a healthy diet. Whereas insoluble dietary fiber promotes colonic motility and gastrointestinal function mainly through physical bulking effects, soluble dietary fiber such as resistant maltodextrin and oligofructose has shown diverse health benefits both locally in the gastrointestinal tract and systemically throughout the body (8, 9) . Agarose, the main component of polysaccharides in agar, is hydrolyzed easily in acetic conditions to yield water soluble oligosaccharides (10) . The resultant oligosaccharides, which are agaro-oligosaccharides (AGOs; Agaphytose TM ), have been investigated widely in terms of their structure and bioactivity (11) (12) (13) (14) . A recent report has described AGOs as preventing gut dysbiosis in mice without influence in the obese phenotype and serum metabolic parameters in abnormal high-fat dietfed conditions (15) . However, several dietary components such as oligofructose and epigallocatechin gallate decrease adipose deposition in a normal diet-fed conditions; these functions are mediated respectively by the acceleration of L-cell differentiation or alteration of microbial composition (9, 16) . For this study, we evaluated the effects of AGOs on an obese phenotype in normal diet-fed mice. Additionally, to investigate the precise effects of AGO on gut microbiota, we applied 16S rRNA gene sequencing analyses.
MATERIALS AND METHODS

Preparation of agaro-oligosaccharides.
The commercial AGOs used for this study were gifts from Takara Bio Inc. (Shiga, Japan). AGOs have repeating agarobiose units composed of d-galactose at the non-reducing end and 3,6-anhydro-l-galactose at the reducing end. AGOs contain four kinds of oligosaccharides which have different degrees of polymerization, termed agarobiose, agarotetraose, agarohexaose, and agarooctaose, respectively (10) .
Animals. Five-week-old male C57BL/6N mice used for this study were obtained from Shimizu Laboratory Supplies Co. Ltd. (Kyoto, Japan). Mice were kept at 18-24˚C and 40-70% relative humidity, with a 12-h light/dark cycle. They were allowed free access to water and diet (CE-2; CLEA Japan, Inc., Tokyo, Japan) for 1 wk during their acclimatization period. Experimental procedures were conducted in accordance with the NIH guidelines for the use of animals in experiments. All experimental protocols were approved by the Animal Care Committee of Kyoto Prefectural University of Medicine (permission number M26-247). After acclimatization, the mice were divided into two groups of six mice each. AGO was supplemented in the drinking water at a concentration of 3% (w/w) for 8 wk. Food intake was calculated on a twice weekly basis until the end of the study and expressed as the average of daily intake. During the 4-wk feeding period, fresh stool samples were obtained from each mouse. Thereafter, the mice were killed under anesthesia without arranging a fasting period. Their blood, epididymal adipose tissue, and cecal contents were collected immediately.
Serum biochemical analysis. Blood supernatants were obtained as serum after centrifugation at 1,500 3g for 10 min. Concentrations of triglycerides (TGs), total cholesterol (T-Cho), and non-esterified fatty acid (NEFA) in serum were measured at SRL Inc. (Tokyo, Japan).
Determination of serum bile acid profile. Serum bile acid profiles were determined using a LC-MS/MS system according to the method described by Ando et al. (17) . In brief, 2 H-labeled internal standards and 2 mL of 0.5 m potassium phosphate buffer (pH 7.4) were added to 20 mL mouse serum. The mixture was passed through a cartridge (200 mg, Bond Elut C18; Agilent Technologies Inc., Santa Clara, CA). Target molecules were eluted in water/ethanol (1 : 9, vol/vol). The eluate was evaporated to dryness under nitrogen and was redissolved in 20 mm ammonium acetate buffer (pH 7.5)/methanol (1 : 1, vol/vol). An aliquot of the resultant sample solution was injected into the LC-MS/MS system for analysis. Chromatographic separation was performed using a column (15032.1 mm, 3 mm, Hypersil GOLD; Thermo Fisher Scientific Inc., Waltham, MA). A mixture of 20 mm ammonium acetate buffer (pH 7.5), acetonitrile, and methanol (70 : 15 : 15, vol/vol/vol) was used as the initial mobile phase and was changed gradually to 30 : 35 : 35 (vol/vol/vol) over 30 min.
Microbiota analysis by 16S rRNA gene sequencing. Fecal samples were suspended in lysis buffer (4 m guanidinium thiocyanate, 100 mm Tris-HCl (pH 9.0), 40 mm ethylenediaminetetraacetic acid, and 0.001% bromothymol blue) and were shaken in the presence of zirconia beads. Then the DNA was extracted from the resultant suspension (Magtration System 12GC and GC series MagDEA DNA 200; Precision System Science Co. Ltd., Chiba, Japan). Microbiota analyses by 16S rRNA gene sequencing were conducted by Takara Bio Inc. The V3-V4 region was amplified using forward primer 341F (5′-TCGTCGGCAGCGTCAGATGTGTATAAGAGA-CAGCCTACGGGNGGCWGCAG-3′) and reverse primer 806R (5′-GTCTCGTGGGCTCGGAGATGTGTATAAGAGA-CAGGGACTACHVGGGTWTCTAAT-3'). The italicized sequences in the primers are the Illumina overhang adaptor. PCR amplification was done using the following program: initial denaturation at 94˚C for 1 min; 28 cycles of 98˚C for 10 s, 50˚C for 15 s, 68˚C for 15 s; and a hold at 4˚C. The amplicons were adapted with Illumina sequencing adapters and dual-index barcode sequences using a kit (Nextera XT Index; Illumina Inc., San Diego, CA), after which they were purified (AMPure XP Beads; Beckman Coulter Inc., Brea, CA) according to the manufacturer's instructions. The purified amplicon library was sequenced on an Illumina Miseq platform (Illumina Inc.). Post-processing sequencing data were analyzed using the Quantitative insights into Microbial Ecology (QIIME) pipeline (ver. 1.8.0.) (18) . Paired-end reads were assembled using the default parameters. Sequence reads with average quality ,Q20 were removed. Chimeric sequences were removed using Usearch V6.1.544, based on the Uchime algorithm implemented in QIIME (19) . Clean Fastq data were aligned into operational taxonomic units (OTUs) at 97% similarity, using openreference OTU picking against the 16S database (Greengenes database ver. 13.8) (20) . Taxonomic identification was performed at the phylum and genus levels. The representative (most abundant) sequence of each genus was investigated using BLAST searches (http://blast. ncbi.nlm.nih.gov/Blast.cgi) to confirm the closest species. Alpha and beta diversity indices were computed at a sequence depth of 276,261 sequences for the sample of lowest sequence. Principal coordinate analysis (PCoA) was performed to plot the variation in the unweighted UniFrac distance between samples. In addition, the unweighted-pair group method using arithmetic means (UPGMA) clustering was performed on unweighted UniFrac distance matrices to build an UPGMA tree. Statistical analysis. Comparisons of two groups were performed using the Mann-Whitney U test. Statistical analyses were applied using software (GraphPad Prism ver. 5.02; GraphPad Software Inc., San Diego, CA). All results are expressed as mean6SE. Differences were regarded as statistically significant for p values of ,0.05 (*), ,0.01 (**), and ,0.001 (***).
RESULTS
Effects of AGO administration on adiposity
Six-week-old mice were administered 3% AGO for 8 wk (AGO-receiving mice). AGO administration had no effect on body weight gain or food intake (Figs. 1a,  1b) . However, AGO administration reduced epididymal adipose tissue weight significantly relative to the control (Fig. 1c) . Next, we determined the weight of cecal contents as a marker of fermentation. As presented in Fig.  1d , the cecal content weights were significantly higher in AGO-receiving mice than in controls.
The biochemical parameters of the serum obtained from mice administered with AGO are presented in Fig.  2 . AGO-receiving mice exhibited significantly lower serum NEFA concentration (Fig. 2a) . No appreciable differences in TG or T-Cho concentrations were found between the two groups (Figs. 2b, 2c) . Figure 2d shows bile acid concentrations in sera obtained from mice administered with AGO. The concentration of cholic acid (CA) and chenodeoxycholic acid (CDCA), which are primary bile acids, tended to increase in AGO-receiving mice (CA: p50.06, CDCA: p50.09). The concentrations of deoxycholic acid (DCA) and lithocholic acid (LCA), which are cytotoxic secondary bile acids, were unaffected (DCA: p50.82, LCA: p50.32). The concentration of ursodeoxycholic acid (UDCA) was also unaffected (p50.13). 
Effects of AGO administration on gut microbiota
Diet strongly affects the composition and activity of the gut microbiota (21) . To assess changes in the microbial community induced by AGO, variable regions V3-V4 of 16S rRNA genes extracted from the stool samples from the mice in each group were sequenced using Illumina MiSeq platforms. The results are presented as OTUs using a 97% homology cutoff value. The phylogenic differences within gut microbiota were assessed using the PCoA method (Fig. 3a) . The AGO-receiving mice exhibited a distinct microbiota composition that clustered separately from that of the control mice. As depicted in Fig. 3b , hierarchical clustering also demonstrated that the microbial composition in the stool of AGO-receiving mice differed from that of control mice. Regarding microbial diversity, AGO administration had no effect on the community richness, or evenness (data not shown).
To evaluate AGO administration effects on gut microbial composition precisely, we compared the relative abundance of the entire detected taxa in each group (Fig. 4) . At the phylum level, the AGO administration led to significantly lower relative abundance of Verrucomicrobia and TM7 than in control mice (Fig. 4a) . Phylum Verrucomicrobia of this study consisted of only genus Akkermansia. Therefore, a result of the phylum Verrucomicrobia reflected a result of genus Akkermansia directly. Phylum TM7 is unculturable, and its physiological properties are unclear. At the genus level, the AGOreceiving mice's microbial community showed significantly greater abundance of Bacteroides, Ruminococcus, Blautia, Dorea, and Desulfovibrio (Fig. 4b) . The relative abundances of Corynebacterium, Butyricimonas, Prevotella, Rikenellaceae, Clostridiaceae, Lachnospiraceae, Sutterella, F16, and Akkermansia were lower in AGOreceiving mice. Furthermore, Pearson correlation analysis revealed that the relative abundances of Rikenellaceae and Lachnospiraceae were positively correlated with epididymal adipose tissue weight, whereas these of Bacteroides and Ruminococcus were correlated negatively with epididymal adipose tissue weight (Fig. 5) . Taken together, these results show that AGO modulates the gut microbiota in mice and fosters microbiota that favor less adipose tissue weight than in control mice.
DISCUSSION
We demonstrated with this study that oral administration of AGO is associated with less fat mass accumulation and serum NEFA concentration in mice, indicating that AGO has anti-obesity effects. Additionally, concentrations of some bile acids in the serum tended to be higher in AGO-receiving mice. Bile acids synthesized in the liver from cholesterol by the action of hepatic enzymes are termed primary bile acids. After excretion into the small intestine, gut microbes convert these bile acids to molecules that are designated as secondary bile acids. In humans, bile acids consist mainly of two primary bile acids, CA and CDCA, and three secondary bile acids, DCA, LCA, and UDCA. Our results demonstrated an association of AGO administration with higher concentrations of primary bile acids, but not those of secondary bile acids. Secondary bile acids, especially DCA, contribute to increased reactive oxygen species, DNA damage, genomic instability, and tumor growth (22) (23) (24) . Aside from their key roles in lipolysis and fat absorption, some bile acids function as ligands of farnesoid X receptor and G protein-coupled bile acid receptor 1 (also known as TGR5) and thereby regulate lipid metabolism (25, 26) . Watanabe et al. (26) reported that activation of TGR5 mediated by bile acids promotes energy expenditure in skeletal muscle and brown adipose tissues. Serum NEFA is consumed as an energy source in several peripheral tissues. Therefore, the AGOmediated reduction of serum NEFA concentration might result from TGR5 activation by bile acids. Consequently, alterations of bile acid concentrations might be associated with anti-obesity effects of AGO.
Indigestible carbohydrates including oligosaccharides were fermented and used by microbiota without degradation by digestive enzymes of the host. Consequently, administration of indigestible carbohydrates affects the gut microbial composition (27, 28) . Indeed, the relative abundances of 15 taxa differed considerably between AGO-receiving mice and control mice. After identifying the most abundant sequences in each taxon, the closest species of these sequences were determined by a homology search using the basic local alignment search tool (BLAST) of the GenBank database ( Table 1) . Results of 16S rRNA gene sequencing analyses showed that AGO administration was significantly associated with higher relative abundances of Blautia, Dorea, Desulfovibrio, Bacteroides, and Ruminococcus. Blautia schinkii and Clostridium oroticum can ferment d-galactose, the main component of AGO (29, 30) . Bacteria belonging to the genus Desulfovibrio use the metabolites of carbohydrate fermentation such as short chain fatty acids (31) . These data suggest that AGO administration directly affects the relative abundances of Blautia, Dorea, and Desulfovibrio. The physiological features of Bacteroides acidifaciens and Clostridium fusiformis have not been clarified. Therefore, the reasons for the elevations of these genera remain unclear. However, the abundances of Bacteroides (most abundant sequence: Bacteroides acidifaciens) and Ruminococcus (most abundant sequence: Clostridium fusiformis) correlated negatively with the weight of epididymal adipose tissue. Most recently, Yang et al. (32) reported that Bacteroides acidifaciens was significantly increased in feces of dendritic cell-specific autophagyrelated gene 7 (Atg7)-deleted mice, and that the body weight and fat mass of the mice were reduced when compared with control mice. Furthermore, mice fed with Bacteroides acidifaciens showed elevated concentrations of insulin and glucagon-like peptide-1 in the serum, thereby reducing the body weight and fat mass.
Clostridium fusiformis was reduced significantly in feces of high-fat sucrose diet-induced obese rats (33) . It is particularly interesting that Thomas et al. (34) reported Clostridium fusiformis as widely predominant in barrier flora and as producing a barrier effect against Clostridium difficile infection, suggesting that Clostridium fusiformis is a beneficial bacterium for human health. Taken together, these data suggest that Bacteroides acidifaciens and Clostridium fusiformis have potential for the treatment of metabolic diseases. The relative abundances of 10 taxa were significantly lower in AGO-receiving mice than in control mice. Of these, the relative abundances of Rikenellaceae (most abundant sequence: uncultured bacterium clone SWPT19) and Lachnospiraceae (most abundant sequence: Dorea formicigenerans) were correlated positively with epididymal adipose tissue weight. Although no correlation has been reported between Dorea formicigenerans and obesity, the abundance of this strain was increased significantly in feces of ulcerative colitis patients compared with that of healthy controls (35) . Uncultured bacterium clone SWPT19 was isolated from mouse feces (36) . However, the physiological features of this clone have not been clarified. Clostridium saudii was isolated from the feces of an obese 24-y-old person (37) , suggesting that this species is a characteristic bacterium of the obese phenotype. Parasutterella excrementihominis and Corynebacterium stationis were isolated, respectively, from human feces and mouse lung (38, 39) . Butyricimonas virosa, isolated from rat feces, was found to be a butyric-acid-producing bacterium (40) . However, no correlation was found between these species and obesity. With regard to Prevotella and F16, their most abundant sequences were uncultured, respectively, bacterium clone Evans.12.4 and clone LFDE2598FG11. Both of these clones were detected in mouse feces (41, 42) . It is particularly interesting that uncultured bacterium clone LFDE2598FG11 was not detected in feces of any AGO-receiving mouse, meaning that this clone is highly susceptible to AGO and/or its metabolite. Consequently, this clone might be deeply associated with several bioactivities of AGO such as anti-inflammatory and anti-carcinogenic effects.
We showed herein that the relative abundance of Akkermansia (most abundant sequence: Akkermansia muciniphila) was significantly lower in AGO-receiving The letters in front of the bacterial names identify the lowest level of classification (f: family and g: genus).
mice. Akkermansia muciniphila is an intestinal mucindegrading bacterium (43) . Li et al. (44) reported that administration of bamboo shoots reduced the body weight gain and fat mass in high-fat-diet-fed mice. The relative abundance of Akkermansia was lower in the bamboo shoot-fed group. This finding is consistent with our obtained data. In contrast, previous reports have described stated that polyphenols from cranberry and apple prevented high-fat-diet-induced obesity and increased the relative abundance of Akkermansia (45, 46) . Consequently, the relation between Akkermansia abundance and obesity remains controversial. It remains the focus of intense investigation. Taira et al. (47) reported that some dietary polyphenols markedly elevated the amount of fecal mucin, suggesting that polyphenol-mediated induction of Akkermansia might result from the mucin production-promoting effects.
In conclusion, results presented herein indicate that the weights of epididymal adipose tissue of AGOreceiving mice were suppressed compared to those of the control mice, suggesting that modulation of the gut microbes by AGO might contribute to its anti-obesity effects. To elucidate the definitive role of gut microbes of AGO-receiving mice, further investigations using fecal transplantation must be conducted. However, our data demonstrate the possibility that oral intake of AGO prevents obesity and its related disorders.
